Cas 1312689-18-1,(Z)-hexyl amino-(4-((1-benzylpyrazole-4-carbonylamino)methyl)phenyl)methylenecarbamate

1312689-18-1

Post Buying Request

Basic information

Product Name: (Z)-hexyl amino-(4-((1-benzylpyrazole-4-carbonylamino)methyl)phenyl)methylenecarbamate
Synonyms: (Z)-hexyl amino-(4-((1-benzylpyrazole-4-carbonylamino)methyl)phenyl)methylenecarbamate
CAS NO:1312689-18-1
Molecular Formula:
Molecular Weight: 461.564
EINECS: N/A
Product Categories: N/A
Mol File: 1312689-18-1.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (Z)-hexyl amino-(4-((1-benzylpyrazole-4-carbonylamino)methyl)phenyl)methylenecarbamate(CAS DataBase Reference)
NIST Chemistry Reference: (Z)-hexyl amino-(4-((1-benzylpyrazole-4-carbonylamino)methyl)phenyl)methylenecarbamate(1312689-18-1)
EPA Substance Registry System: (Z)-hexyl amino-(4-((1-benzylpyrazole-4-carbonylamino)methyl)phenyl)methylenecarbamate(1312689-18-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1312689-18-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1312689-18-1 Suppliers

Recommended suppliersmore

1312689-18-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1312689-18-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,6,8 and 9 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1312689-18:
(9*1)+(8*3)+(7*1)+(6*2)+(5*6)+(4*8)+(3*9)+(2*1)+(1*8)=151
151 % 10 = 1
So 1312689-18-1 is a valid CAS Registry Number.

1312689-18-1Upstream product

6092-54-2 n-hexyl chloroformate

1312689-18-1Downstream Products

1312689-18-1Relevant articles and documents

PRODRUGS OF INHIBITORS OF PLASMA KALLIKRIEN

-

Page/Page column 13, (2011/07/06)

The present invention provides prodrugs of compounds that inhibit the activity of plasma kallikrein (PK) and methods of preventing and treating plasma kallikrein dependent diseases or conditions, for example, diabetic macular edema, with the prodrugs havi

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1312689-18-1